Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 38,727 | 44,410 | 47,408 | 41,041 | 38,770 |
| Operating Income | -38,727 | -44,410 | -47,408 | -41,041 | -38,770 |
| Interest Expense | 7 | 14 | 25 | 27 | 32 |
| Other Income | 1,947 | 2,343 | 2,798 | 3,579 | 4,310 |
| Pre-tax Income | -36,787 | -42,081 | -44,635 | -37,489 | -34,492 |
| Net Income Continuous | -36,787 | -42,081 | -44,635 | -37,489 | -34,492 |
| Net Income | $-36,787 | $-42,081 | $-44,635 | $-37,489 | $-34,492 |
| EPS Basic Total Ops | -0.85 | -0.97 | -1.03 | -0.74 | -0.80 |
| EPS Basic Continuous Ops | -0.85 | -0.97 | -1.03 | -0.73 | -0.80 |
| EPS Diluted Total Ops | -0.85 | -0.97 | -1.03 | -0.74 | -0.80 |
| EPS Diluted Continuous Ops | -0.85 | -0.97 | -1.03 | -0.73 | -0.80 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -0.97 | -1.03 | -0.88 | -0.80 |
| EBITDA(a) | $-38,312 | $-43,895 | $-46,907 | $-40,478 | $-38,212 |